SMARCA2 and neoplasm: In contrast to previous findings (Chongsathidkiet et al,2018), we did not observe significant differences in CD3+ T‐cell numbers in peripheral blood isolated from BrM‐bearing mice compared with tumor‐free animals (Appendix Fig S3A).